| http://www.w3.org/ns/prov#value | - Preliminary results from the PROPHYSES trial show that CHC patients age 65 and older have lower rates of virologic response even after correcting for factors such as co-morbidities and medication adherence.In this same vein, patients with co-morbid conditions ??? such as chronic cardiopulmonary disorders ??? are another population where treatment now may be beneficial.
|
